Srsn.Jk
SRSN.JK is a diversified chemicals company operating in the Basic Materials sector, primarily generating revenue through the production and sale of a wide range of chemical products.
Business. SRSN.JK is a diversified chemicals company operating in the Basic Materials sector, primarily generating revenue through the production and sale of a wide range of chemical products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
SRSN.JK is a diversified chemicals company operating in the Basic Materials sector, primarily generating revenue through the production and sale of a wide range of chemical products.
SRSN.JK maintains a relatively strong liquidity position, with a current ratio of 2.93, indicating the company can cover its short-term liabilities nearly three times over. However, the company's liquidity risk is assessed as medium, and its net cash position is negative after subtracting total debt, suggesting potential pressure on short-term financial flexibility.
In terms of profitability, SRSN.JK reports a return on equity (ROE) of 9.55% and a return on assets (ROA) of 7.35%, both of which are strong indicators of efficient capital use and asset management. These figures suggest the company is outperforming the typical industry benchmarks for Diversified Chemicals, where ROE and ROA are often lower due to the capital-intensive nature of the sector.
The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no specific geographic breakdown provided in the available data. This lack of diversification may expose the company to regional economic fluctuations, though the extent of geographic risk cannot be assessed without further data.
Looking ahead, SRSN.JK is expected to maintain a stable growth trajectory, supported by its strong operating cash flow of 255.8 billion IDR and a free cash flow of 56.0 billion IDR. The company's capital expenditures of 35.0 billion IDR indicate ongoing investment in infrastructure and operations, which may support future revenue expansion.
The risk assessment for SRSN.JK highlights a low dilution risk, with no significant dilution potential identified in the basic shares outstanding. However, the company's debt-to-equity ratio of 0.14 suggests a conservative capital structure, with long-term debt at 109.9 billion IDR and total equity at 809.8 billion IDR. No recent events or filings have been disclosed that would significantly alter the company's risk profile or financial outlook.
- SRSN.JK maintains a strong liquidity position with a current ratio of 2.93, indicating solid short-term financial health.
- The company's ROE of 9.55% and ROA of 7.35% suggest efficient use of equity and assets, outperforming typical industry benchmarks.
- SRSN.JK's capital expenditures of 35.0 billion IDR indicate ongoing investment in infrastructure and operations, supporting future growth.
- The company's low dilution risk and conservative debt-to-equity ratio of 0.14 suggest a stable and resilient capital structure.
- "margin_outlook_rationale": "The company's gross profit margin is expected to remain stable due to consistent cost management and pricing power in its core markets.",
- "rd_outlook_rationale": "Research and development spending is expected to remain moderate, as the company focuses on optimizing existing product lines rather than pursuing high-risk innovation.",
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- SRSN.JK Market data — financials · 2026-05-29